RPA1 and infection: Notably, our CRISPR-Cas12a/RPA approach complements recent findings by Huang et al. [33]., who demonstrated that bacterial-derived sialidases inhibit PoRV OSU replication by targeting α-2,3-linked sialic acid receptors during early infection stages.